(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACAT1 mRNA] CTD PMID:31150632 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein] CTD PMID:10656290 1,1-dichloroethene decreases expression ISO RGD:10060 6480464 vinylidene chloride results in decreased expression of ACAT1 mRNA CTD PMID:26682919 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of ACAT1 protein CTD PMID:17337753 1,2-dimethylhydrazine decreases expression ISO RGD:10060 6480464 1, 2-Dimethylhydrazine results in decreased expression of ACAT1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10060 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACAT1 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases oxidation EXP 6480464 3-dinitrobenzene results in increased oxidation of ACAT1 protein CTD PMID:25716674 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of ACAT1 mRNA CTD PMID:25380136 , PMID:30723492 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ACAT1 mRNA CTD PMID:26496021 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACAT1 protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10060 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACAT1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10060 6480464 Tetrachlorodibenzodioxin affects the expression of ACAT1 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACAT1 mRNA CTD PMID:21215274 , PMID:34747641 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ACAT1 mRNA CTD PMID:21346803 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of ACAT1 mRNA CTD PMID:21427058 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ACAT1 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of ACAT1 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737017 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACAT1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ACAT1 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions ISO RGD:737017 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACAT1 mRNA CTD PMID:28628672 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:737017 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 7-ketocholesterol multiple interactions ISO RGD:737017 6480464 [7-ketocholesterol co-treated with KNG1 protein modified form] results in decreased expression of ACAT1 mRNA, [7-ketocholesterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA CTD PMID:23454145 7H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of ACAT1 protein CTD PMID:19464573 9H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of ACAT1 protein CTD PMID:19464573 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ACAT1 mRNA CTD PMID:31881176 acrylamide multiple interactions ISO RGD:10060 6480464 Acrylamide inhibits the reaction [Streptozocin results in decreased expression of ACAT1 mRNA] CTD PMID:34896238 acrylamide decreases expression ISO RGD:10060 6480464 Acrylamide results in decreased expression of ACAT1 mRNA CTD PMID:34896238 aflatoxin B1 decreases expression ISO RGD:10060 6480464 Aflatoxin B1 results in decreased expression of ACAT1 mRNA CTD PMID:19770486 amiodarone increases expression ISO RGD:10060 6480464 Amiodarone results in increased expression of ACAT1 mRNA CTD PMID:24489787 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ACAT1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:737017 6480464 Antirheumatic Agents results in increased expression of ACAT1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:737017 6480464 aristolochic acid I results in decreased expression of ACAT1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:737017 6480464 arsenite promotes the reaction [G3BP1 protein binds to ACAT1 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:737017 6480464 Arsenic Trioxide results in increased expression of ACAT1 mRNA CTD PMID:22521957 atrazine decreases expression ISO RGD:737017 6480464 Atrazine results in decreased expression of ACAT1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:10060 6480464 Benzo(a)pyrene results in decreased expression of ACAT1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:737017 6480464 Benzo(a)pyrene results in decreased expression of ACAT1 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression ISO RGD:10060 6480464 Benzo(a)pyrene results in increased expression of ACAT1 mRNA CTD PMID:22228805 bexarotene multiple interactions EXP 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of ACAT1 mRNA CTD PMID:17630414 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ACAT1 mRNA CTD PMID:16648578 , PMID:17630414 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ACAT1 mRNA, [bisphenol A co-treated with tributyltin] results in increased expression of ACAT1 mRNA CTD PMID:26496021 , PMID:31129395 bisphenol A decreases expression ISO RGD:737017 6480464 bisphenol A results in decreased expression of ACAT1 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:10060 6480464 bisphenol A results in decreased expression of ACAT1 mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACAT1 mRNA CTD PMID:30816183 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACAT1 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:737017 6480464 bisphenol B results in increased expression of ACAT1 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:737017 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:737017 6480464 bisphenol F results in increased expression of ACAT1 protein CTD PMID:34186270 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ACAT1 mRNA CTD PMID:33453195 cadmium dichloride increases expression ISO RGD:737017 6480464 Cadmium Chloride results in increased expression of ACAT1 protein CTD PMID:24527689 carbon nanotube increases expression ISO RGD:10060 6480464 Nanotubes more ... CTD PMID:25620056 chenodeoxycholic acid decreases expression ISO RGD:737017 6480464 Chenodeoxycholic Acid results in decreased expression of ACAT1 mRNA CTD PMID:27174168 cisplatin increases expression ISO RGD:737017 6480464 Cisplatin results in increased expression of ACAT1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:10060 6480464 Cisplatin results in decreased expression of ACAT1 mRNA CTD PMID:35367536 cisplatin multiple interactions ISO RGD:10060 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACAT1 mRNA] CTD PMID:35367536 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ACAT1 protein CTD PMID:16470657 clofibrate increases expression ISO RGD:10060 6480464 Clofibrate results in increased expression of ACAT1 mRNA CTD PMID:23811191 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ACAT1 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ACAT1 mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:737017 6480464 Copper Sulfate results in decreased expression of ACAT1 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:737017 6480464 Asbestos, Crocidolite results in increased expression of ACAT1 mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:737017 6480464 Cyclosporine results in decreased expression of ACAT1 mRNA CTD PMID:20106945 , PMID:23830897 cyclosporin A decreases expression ISO RGD:10060 6480464 Cyclosporine results in decreased expression of ACAT1 mRNA CTD PMID:19770486 , PMID:23830897 cyproconazole decreases expression ISO RGD:10060 6480464 cyproconazole results in decreased expression of ACAT1 mRNA CTD PMID:22334560 DDT decreases expression EXP 6480464 DDT results in decreased expression of ACAT1 mRNA, DDT results in decreased expression of ACAT1 protein CTD PMID:32508177 dexamethasone multiple interactions ISO RGD:737017 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACAT1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:737017 6480464 Arsenic Trioxide results in increased expression of ACAT1 mRNA CTD PMID:22521957 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ACAT1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:10060 6480464 Dibutyl Phthalate results in decreased expression of ACAT1 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:737017 6480464 dicrotophos results in decreased expression of ACAT1 mRNA CTD PMID:28302478 doxorubicin decreases expression ISO RGD:737017 6480464 Doxorubicin results in decreased expression of ACAT1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ACAT1 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:737017 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACAT1 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:10060 6480464 epoxiconazole results in decreased expression of ACAT1 mRNA CTD PMID:22334560 farnesol increases expression ISO RGD:737017 6480464 Farnesol analog results in increased expression of ACAT1 mRNA CTD PMID:30611723 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ACAT1 mRNA CTD PMID:18253720 fenofibrate increases expression ISO RGD:737017 6480464 Fenofibrate results in increased expression of ACAT1 mRNA CTD PMID:24752549 finasteride increases expression EXP 6480464 Finasteride results in increased expression of ACAT1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:10060 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACAT1 mRNA CTD PMID:22206623 furan affects binding EXP 6480464 furan binds to ACAT1 protein CTD PMID:22240984 GDP-beta-S multiple interactions ISO RGD:737017 6480464 guanosine 5'-O-(2-thiodiphosphate) inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] CTD PMID:16157345 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ACAT1 mRNA CTD PMID:22061828 GW 4064 decreases expression ISO RGD:737017 6480464 GW 4064 results in decreased expression of ACAT1 mRNA CTD PMID:30611723 GW 4064 multiple interactions ISO RGD:737017 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACAT1 mRNA CTD PMID:30611723 haloperidol decreases expression ISO RGD:737017 6480464 Haloperidol results in decreased expression of ACAT1 protein CTD PMID:34122009 indometacin multiple interactions ISO RGD:737017 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACAT1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA CTD PMID:28628672 irinotecan increases response to substance ISO RGD:737017 6480464 ACAT1 protein results in increased susceptibility to Irinotecan CTD PMID:16734730 isobutanol multiple interactions ISO RGD:737017 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACAT1 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:737017 6480464 Ivermectin results in decreased expression of ACAT1 protein CTD PMID:32959892 lead diacetate decreases expression ISO RGD:10060 6480464 lead acetate results in decreased expression of ACAT1 mRNA CTD PMID:21829687 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of ACAT1 mRNA CTD PMID:24136188 melatonin multiple interactions ISO RGD:10060 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACAT1 mRNA] CTD PMID:35367536 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of ACAT1 mRNA CTD PMID:30467583 morphine multiple interactions EXP 6480464 Morphine deficiency affects the reaction [Morphine results in decreased expression of ACAT1 protein] CTD PMID:23056601 morphine decreases expression EXP 6480464 Morphine results in decreased expression of ACAT1 protein CTD PMID:23056601 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of ACAT1 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium increases expression ISO RGD:10060 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ACAT1 protein CTD PMID:26558463 N-nitrosodiethylamine multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ACAT1 mRNA CTD PMID:18253720 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of ACAT1 mRNA CTD PMID:25380136 nitroglycerin increases expression EXP 6480464 Nitroglycerin results in increased expression of ACAT1 mRNA CTD PMID:12102619 oleic acid multiple interactions ISO RGD:737017 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 ozone increases expression EXP 6480464 Ozone results in increased expression of ACAT1 protein CTD PMID:33146391 paracetamol affects expression ISO RGD:10060 6480464 Acetaminophen affects the expression of ACAT1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:737017 6480464 Acetaminophen results in decreased expression of ACAT1 mRNA CTD PMID:25704631 , PMID:29067470 paracetamol increases expression ISO RGD:10060 6480464 Acetaminophen results in increased expression of ACAT1 protein CTD PMID:11752693 perfluorohexanesulfonic acid increases expression ISO RGD:10060 6480464 perfluorohexanesulfonic acid results in increased expression of ACAT1 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ACAT1 mRNA CTD PMID:18692542 , PMID:19162173 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:10060 6480464 perfluorooctane sulfonic acid results in decreased expression of ACAT1 protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10060 6480464 PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of ACAT1 mRNA] CTD PMID:20936131 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10060 6480464 perfluorooctane sulfonic acid results in increased expression of ACAT1 mRNA CTD PMID:20936131 , PMID:21705711 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ACAT1 mRNA, perfluorooctanoic acid results in increased expression of ACAT1 protein CTD PMID:16221955 more ... perfluorooctanoic acid increases expression ISO RGD:10060 6480464 perfluorooctanoic acid results in increased expression of ACAT1 mRNA CTD PMID:30657992 perfluorooctanoic acid increases expression ISO RGD:737017 6480464 perfluorooctanoic acid results in increased expression of ACAT1 protein CTD PMID:26879310 phenobarbital multiple interactions ISO RGD:10060 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ACAT1 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:10060 6480464 Phenobarbital affects the expression of ACAT1 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ACAT1 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:10060 6480464 Phenobarbital results in decreased expression of ACAT1 mRNA CTD PMID:19482888 phlorizin decreases expression ISO RGD:10060 6480464 Phlorhizin results in decreased expression of ACAT1 mRNA CTD PMID:22538082 phosphatidylcholine decreases activity EXP 6480464 Phosphatidylcholines results in decreased activity of ACAT1 protein CTD PMID:12559476 picoxystrobin increases expression ISO RGD:737017 6480464 picoxystrobin results in increased expression of ACAT1 mRNA CTD PMID:33512557 pioglitazone decreases expression ISO RGD:737017 6480464 pioglitazone results in decreased expression of ACAT1 mRNA CTD PMID:15381068 pirinixic acid multiple interactions ISO RGD:10060 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACAT1 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ACAT1 mRNA CTD PMID:16940010 more ... pirinixic acid increases expression ISO RGD:10060 6480464 pirinixic acid results in increased expression of ACAT1 mRNA, pirinixic acid results in increased expression of ACAT1 protein CTD PMID:15226431 more ... platycodin D decreases activity ISO RGD:737017 6480464 platycodin D results in decreased activity of ACAT1 protein CTD PMID:16626693 potassium dichromate increases expression ISO RGD:737017 6480464 Potassium Dichromate results in increased expression of ACAT1 mRNA CTD PMID:18332044 pravastatin decreases expression ISO RGD:10060 6480464 Pravastatin results in decreased expression of ACAT1 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of ACAT1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of ACAT1 mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:10060 6480464 propiconazole results in decreased expression of ACAT1 mRNA CTD PMID:21278054 , PMID:22334560 quercetin decreases expression ISO RGD:737017 6480464 Quercetin results in decreased expression of ACAT1 mRNA CTD PMID:21632981 rac-1,2-dichloropropane decreases expression ISO RGD:10060 6480464 propylene dichloride results in decreased expression of ACAT1 protein CTD PMID:32435916 rac-1,2-dichloropropane multiple interactions ISO RGD:10060 6480464 1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of ACAT1 protein] CTD PMID:32435916 resveratrol multiple interactions ISO RGD:737017 6480464 Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of ACAT1 protein] CTD PMID:26027833 rotenone multiple interactions ISO RGD:737017 6480464 [7-ketocholesterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA, [Stigmasterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA CTD PMID:23454145 rottlerin multiple interactions ISO RGD:737017 6480464 rottlerin inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] CTD PMID:16157345 sarpogrelate multiple interactions ISO RGD:737017 6480464 sarpogrelate inhibits the reaction [Serotonin results in increased expression of ACAT1 protein], sarpogrelate metabolite inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] CTD PMID:16157345 serotonin increases expression ISO RGD:737017 6480464 Serotonin results in increased expression of ACAT1 mRNA alternative form CTD PMID:16157345 serotonin multiple interactions ISO RGD:737017 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] more ... CTD PMID:16157345 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ACAT1 protein CTD PMID:29459688 soybean oil decreases activity EXP 6480464 Soybean Oil results in decreased activity of ACAT1 protein CTD PMID:12559476 stigmasterol multiple interactions ISO RGD:737017 6480464 [Stigmasterol co-treated with KNG1 protein modified form] results in decreased expression of ACAT1 mRNA more ... CTD PMID:23454145 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of ACAT1 protein CTD PMID:19634143 streptozocin multiple interactions ISO RGD:10060 6480464 Acrylamide inhibits the reaction [Streptozocin results in decreased expression of ACAT1 mRNA] CTD PMID:34896238 streptozocin decreases expression ISO RGD:10060 6480464 Streptozocin results in decreased expression of ACAT1 mRNA CTD PMID:34896238 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACAT1 protein] CTD PMID:19634143 tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of ACAT1 mRNA CTD PMID:17630414 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of ACAT1 mRNA CTD PMID:17630414 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of ACAT1 mRNA CTD PMID:17630414 temozolomide increases expression ISO RGD:737017 6480464 Temozolomide results in increased expression of ACAT1 mRNA CTD PMID:31758290 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ACAT1 mRNA CTD PMID:21515302 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACAT1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:10060 6480464 Carbon Tetrachloride results in decreased expression of ACAT1 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ACAT1 mRNA CTD PMID:31150632 tetracycline decreases expression ISO RGD:10060 6480464 Tetracycline results in decreased expression of ACAT1 mRNA CTD PMID:24489787 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ACAT1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:737017 6480464 titanium dioxide results in decreased expression of ACAT1 protein CTD PMID:30910687 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of ACAT1 mRNA CTD PMID:31129395 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ACAT1 mRNA CTD PMID:21515302 tunicamycin decreases expression ISO RGD:737017 6480464 Tunicamycin results in decreased expression of ACAT1 mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:737017 6480464 Urethane results in decreased expression of ACAT1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:10060 6480464 Valproic Acid results in increased expression of ACAT1 mRNA CTD PMID:24489787 valproic acid decreases expression ISO RGD:737017 6480464 Valproic Acid results in decreased expression of ACAT1 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:737017 6480464 Valproic Acid affects the expression of ACAT1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:737017 6480464 Valproic Acid results in increased expression of ACAT1 mRNA CTD PMID:23179753 vancomycin increases expression ISO RGD:10060 6480464 Vancomycin results in increased expression of ACAT1 mRNA CTD PMID:18930951 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of ACAT1 mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:10060 6480464 squalestatin 1 results in decreased expression of ACAT1 mRNA CTD PMID:27225895